Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × Prednisolone × Clear all

NCT00513955 2014-11-05

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Mantle-Cell